Navigation Links
The surprising story of Charles Darwin and his homeopathic doctor
Date:12/12/2007

A new scholarly written book describes hundreds of well-known and respected physicians, scientists, politicians, corporate leaders, and literary greats who used or advocated for homeopathic medicine. Eleven U.S. Presidents, seven popes, Sir William Osler, J.D. Rockefeller, Charles Kettering, and C. Everett Koop are among those famous people who were known to have benefited from homeopathy. Perhaps most surprisingly is the evidence of Charles Darwins use of homeopathic medicines and the significant results he received from them.

In the new book, The Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy (North Atlantic Books, 2007), Dana Ullman presents strong evidence derived primarily from Charles Darwins own letters about the treatment he received from a homeopathic physician. Ullman suggests that Charles Darwin would not have lived long enough to have completed his seminal work, The Origin of Species, in 1859 if he didnt get homeopathic treatment ten years previously.

It is well known that Darwin became very ill during his trip to South America in the late 1830s. His health continued to decline, and he was so ill that he couldnt attend his own fathers funeral in 1848. He suffered from severe and constant nausea, heart palpitations, widespread boils, and trembling for 12 years, and by 1849, he had suffered from fainting spells and spots before his eyes for two years. According to Darwins letters, he was not able to work one day in every three.

Finally, in 1849, he sought the treatment from Dr. James Manby Gully, a homeopathic physician who owned a hydrotherapy spa. Although Darwin was skeptical of homeopathy, he obediently took the prescription of homeopathic medicines his doctor gave him, and within a month, his health was considerably better. Darwin didnt have nausea for a month, gained some weight, took a seven mile walk (which he was previously unable to do), and then wrote to a friend, I
'/>"/>

Contact: Dean Draznin
dean@drazninpr.com
641-472-2257
Foundation for Homeopathic Education and Research
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. European Union forests expanding, absorbing carbon at surprisingly high rate: study
2. Story ideas from the Journal of Lipid Research
3. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2007
4. Satellites witness lowest Arctic ice coverage in history
5. Census of protein architectures offers new view of history of life
6. New study sheds light on Galápagos hawk evolutionary history
7. Microfossils disclose geologic history of eastern California
8. Story ideas from Molecular & Cellular Proteomics
9. Story tips from the Department of Energys Oak Ridge National Laboratory, October 2007
10. Story ideas from the Journal of Biological Chemistry
11. Rebuilding the evolutionary history of HIV-1 unravels a complex loop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... of patients with undiagnosed, suspected genetic conditions, a certain ... higher molecular diagnostic yield than traditional molecular diagnostic methods, ... The study is being released to coincide with the ... sequencing, which sequences the protein­coding region of the genome ... in a cell or organism), has been rapidly applied ...
(Date:10/16/2014)... war on the human body. Battles are won, ... pancreatic cancer, this stalemate—known as tumor dormancy—can last ... a phenomena that is poorly understood. , ... of Salvatore Torquato, a Professor of Chemistry at ... tumor dormancy and the switch to a malignant ...
(Date:10/16/2014)... infections and worldwide claims the lives of 160,000 ... University have succeeded in developing a promising vaccination ... , Xavier Saelens (VIB/UGent): "We discovered a new ... development of a novel approach to vaccination against ... small children and elderly people." , RSV: ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Modeling tumor dormancy 2New perspectives for development of an RSV vaccine 2
... National Oceanic and Atmospheric Administration, and the co-trustees for ... announced today they have started the injury assessment and ... a legal process to determine the type and amount ... to natural resources and their human uses as a ...
... Troy, N.Y. The purification of drug components ... is particularly true of drugs that utilize proteins, which ... impurities. Scientists within the Center for Biotechnology and Interdisciplinary ... magnetic resonance (NMR) to understand and improve an important ...
... The National Institute of Neurological Disorders and Stroke (NINDS), ... two new sites as part of the Morris K. Udall ... grants will provide a five-year investment totaling more than $16 ... for Medical Research in Manhasset, N.Y. NINDS ...
Cached Biology News:Resource restoration planning process begins for BP/Deepwater Horizon oil spill 2Resource restoration planning process begins for BP/Deepwater Horizon oil spill 3Purifying proteins: Rensselaer researchers use NMR to improve drug development 2Purifying proteins: Rensselaer researchers use NMR to improve drug development 3NINDS awards new Udall Centers for Parkinson's Disease Research 2NINDS awards new Udall Centers for Parkinson's Disease Research 3
(Date:10/19/2014)... October 20, 2014 OCTOBER ... Meeting (ABIM). ABIM will take place ... information about ABIM 2014 is now available ... Delegates representing companies and organizations from all ... obtain information on the latest products and ...
(Date:10/19/2014)... The Asian Automatic patient billing report defines and segments ... revenue. The Automatic patient billing market in Asia is ... at a developing CAGR of 7.2% from 2013 to ... Automatic patient billing market, to get an idea of ... of the segmentation of this market in the same ...
(Date:10/19/2014)... The Asian Orthopedic braces and support systems ... analysis and forecast of revenue. The Orthopedic braces and support ... $416.5 million by 2018, at a developing CAGR of 4.4% ... the Asian Orthopedic braces and support systems market, to get ... a glimpse of the segmentation of orthopedic braces and support ...
(Date:10/18/2014)... The “Human Insulin Market- by ... Premixed), Modern Human Insulin (Rapid Acting, Long Acting, ... Tresiba, Others) - Forecast to 2018” provides a ... opportunities, current market trends, and strategies impacting the ... and forecasts of the revenue and share analysis. ...
Breaking Biology Technology:The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 2The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 5
... Kevin W. Sharer, chairman and chief executive officer of Amgen ... plan to retire from the Company at the end of ... an orderly transition process, Sharer will step down as CEO ... Company,s Board of Directors until December 31, 2012, at which ...
... OAKS, Calif., Dec. 15, 2011  Amgen (NASDAQ: AMGN ... $0.36 per share dividend for the first quarter of 2012. ... the previous two quarters. The dividend will be paid on ... the close of business on Feb. 15, 2012.  ...
... 15, 2011 Prolong Pharmaceuticals today announced ... spearhead the firms, engineering and facilities planning ...   Having previously directed the construction of the ... Grange Castle facility in Dublin, Ireland, Flachmeyer is ...
Cached Biology Technology:Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012 2Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012 3Amgen Announces 2012 First Quarter Dividend 2Amgen Announces 2012 First Quarter Dividend 3Prolong's Large Scale Manufacturing of Sickle Cell Product to be Headed by Industry Veteran 2